Literature DB >> 3850020

JANA: a new iterative polyexponential curve stripping program.

A Dunne.   

Abstract

A new iterative polyexponential curve stripping technique for the provision of initial pharmacokinetic parameter estimates has been developed. Such estimates are required for nonlinear least-squares curve fitting. In contrast to conventional curve stripping, this new technique does not make any assumption about the relative magnitudes of the exponential rate constants. Hence, the parameter estimates which it provides are free of the bias which may arise in conventional curve stripping. A BASIC program called JANA has been developed to implement the new curve stripping procedure.

Mesh：

Year:  1985        PMID： 3850020     DOI： 10.1016/0169-2607(85)90085-9

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN： 0169-2607            Impact factor:   5.428


  15 in total

1.  Bioavailability of aciclovir after oral administration of aciclovir and its prodrug valaciclovir to patients with leukopenia after chemotherapy.

Authors:  H Steingrimsdottir; A Gruber; C Palm; G Grimfors; M Kalin; S Eksborg
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

2.  Influence of lomefloxacin on the pharmacokinetics of theophylline.

Authors:  M LeBel; F Vallée; M St-Laurent
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

3.  Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. I: Lorazepam.

Authors:  S K Gupta; E H Ellinwood; A M Nikaido; D G Heatherly
Journal:  J Pharmacokinet Biopharm       Date:  1990-04

4.  Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever.

Authors:  D B Bethell; N P Day; N M Dung; C McMullin; H T Loan; D T Tam; L T Minh; N T Linh; N Q Dung; H Vinh; A P MacGowan; L O White; N J White
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

5.  Some pharmacokinetic parameters of doxycycline in east African goats after intramuscular administration of a long-acting formulation.

Authors:  I M Ole-Mapenay; E S Mitema
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459

6.  Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. II. Triazolam.

Authors:  S K Gupta; E H Ellinwood; A M Nikaido; D G Heatherly
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

7.  Comparative absorption and distribution pharmacokinetics of intravenous and epidural sufentanil for major abdominal surgery.

Authors:  R H Taverne; T I Ionescu; S T Nuyten
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

8.  A microdialysis study of glycinamide, glycine and other amino acid neurotransmitters in rat frontal cortex and hippocampus after the administration of milacemide, a glycine pro-drug.

Authors:  M H Doheny; S Nagaki; P N Patsalos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-07       Impact factor: 3.000

9.  Pharmacokinetic evaluations of low- and high-dose zidovudine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection.

Authors:  T A Tartaglione; A C Collier; K Opheim; F G Gianola; J Benedetti; L Corey
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

10.  Single-dose pharmacokinetics of ceftibuten (SCH 39720) in infants and children.

Authors:  G L Kearns; M D Reed; R F Jacobs; M Ardite; R D Yogev; J L Blumer
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.